Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Search Results
Search Results 61 – 80 of 113
Cytomegalovirus Disease
… several ways, including through breastfeeding, perinatally, sexually, viral shedding in bodily fluids (saliva, urine, or … to CMV among adults with HIV, but condoms may reduce sexual transmission of CMV. 31,32 Preventing Disease … . Drew LW. Condoms and the transmission of cytomegalovirus. Sexually Transmitted Diseases . 1998;25(9):481-482. …
https://clinicalinfo.hiv.gov/node/9174
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2025
… males and females when given before exposure to HPV through sexual contact. Administer the first dose at age 11 years or … beginning at 9 years of age, for persons with a history of sexual abuse and assault. HPV vaccine can be administered to … any of the following risk factors: Persons who are gay, bisexual, and other men who have sex with men (MSM) who in the …
https://clinicalinfo.hiv.gov/node/9481
Cobicistat
… With HIV recommends using Stribild only in patients with sexual maturity ratings of 4 or 5. [Symtuza] … HIV recommends limiting the use of Stribild to those with a sexual maturity rating of 4 or 5. COBI, as a component of …
https://clinicalinfo.hiv.gov/node/9448
Human Herpesvirus 8
… parents and siblings in the home, indicating non-sexual transmission for prepubertal children, with a limited … use male latex condoms correctly and consistently during sexual intercourse to reduce exposure to sexually transmitted pathogens. Preventing First Episode of …
https://clinicalinfo.hiv.gov/node/12786
Diagnosis of HIV Infection in Infants and Children
… of HIV during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … HIV diagnosed during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … Additional routes of HIV transmission in children include sexual abuse, receipt of contaminated blood products, and …
https://clinicalinfo.hiv.gov/node/9403
Diagnosis of HIV Infection in Infants and Children
… of HIV during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … HIV diagnosed during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … Additional routes of HIV transmission in children include sexual abuse, receipt of contaminated blood products, and …
https://clinicalinfo.hiv.gov/node/9222
Introduction
… NIH OAR HIV Clinical Guidelines. Unique Considerations Sexual Maturity Rating These guidelines are a companion to … for guidance on the care of postpubertal adolescents (sexual maturity rating [SMR] 4 and 5) and the Pediatric … adolescents at SMR 3 or lower (see Table 1 below). Table 1: Sexual Maturity Rating GIRLS Breast Development Stage Pubic …
https://clinicalinfo.hiv.gov/node/9213
Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents
… renal toxicity. TDF is not recommended for children with sexual maturity ratings of 1 to 3 because of TDF-associated … inhibitor; RPV = rilpivirine; RTV = ritonavir; SMR = sexual maturity rating; TAF = tenofovir alafenamide; TDF = …
https://clinicalinfo.hiv.gov/node/9422
Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease
… primary, secondary, or early latent syphilis. Individuals sexually exposed ≤90 days before the partner’s diagnosis … regardless of syphilis serologic status (AII). Individuals sexually exposed >90 days before the partner’s diagnosis …
https://clinicalinfo.hiv.gov/node/9410
Cytomegalovirus
… when sanitary conditions are suboptimal. Among adolescents, sexual transmission is the major mode of CMV acquisition. … child-rearing practices, crowding, sanitation, and sexual behavior most likely influence age-related variations …
https://clinicalinfo.hiv.gov/node/9391
Previous Experience With Antiretroviral Medications but Not Currently on Antiretroviral Therapy During Current Pregnancy
… to the infant (i.e., perinatal prevention) or the sexual partner. ARV drugs may also have been taken … for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational …
https://clinicalinfo.hiv.gov/node/11891
Special Populations: HIV-2 Infection
… treating people of West African origin, people who have had sexual contact with or shared needles with people of West … ART likely provides a reduced risk of transmission to sexual partners. 53-55 Viral mutations that are associated … TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. …
https://clinicalinfo.hiv.gov/node/9288
What's New in the Guidelines
… HIV status and the need to screen partner(s) for HIV and sexually transmitted infections and provide testing or refer … also discuss whether HIV status has been disclosed to sexual partner(s) and discuss options for PrEP when …
https://clinicalinfo.hiv.gov/node/9453
Lenacapavir (LEN, Sunlenca)
… HIV pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing …
https://clinicalinfo.hiv.gov/node/13006
Updates to the ​Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV​
… With Minor Updates Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention) Adverse …
https://clinicalinfo.hiv.gov/news/actualizaciones-las-guias-para-el-uso-de-agentes-antirretrovirales-en-adultos-y-adolescentes-3
Eritromicina
… infecciones de la piel e infecciones de transmisión sexual . También es un medicamento aprobado por la FDA para …
https://clinicalinfo.hiv.gov/drugs/eritromicina/paciente
VIH e Infecciones Oportunistas, Coinfecciones y Condiciones
… tuberculosis (TB) El VIH y las enfermedades de transmisión sexual (ETS) El VIH y la enfermedad del corazón El VIH y la …
https://clinicalinfo.hiv.gov/news/vih-e-infecciones-oportunistas-coinfecciones-y-condiciones
HIV and Opportunistic Infections, Coinfections, and Conditions
… ? HIV and Hepatitis B HIV and Tuberculosis (TB) HIV and Sexually Transmitted Diseases (STDs) HIV and Heart Disease …
https://clinicalinfo.hiv.gov/news/vih-e-infecciones-oportunistas-coinfecciones-y-condiciones
National Youth HIV/AIDS Awareness Day
… to ensure youth have tools to prevent HIV and other sexually transmitted infections (STIs).  The National …
https://clinicalinfo.hiv.gov/news/el-dia-nacional-de-concientizacion-sobre-el-vih-y-el-sida-en-jovenes
Sponsors
… and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases. The institute also supports …
https://clinicalinfo.hiv.gov/patrocinadores

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Página 2
  • Página 3
  • Página actual 4
  • Página 5
  • Página 6
  • Siguiente página ›
  • Última página »

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.